Lenalidomide for the treatment of relapsed and refractory multiple myeloma

Lenalidomide for the treatment of relapsed and refractory multiple myeloma

Niels WCJ van de Donk,1,2 Güllü Görgün,1 Richard WJ Groen,1,3 Jana Jakubikova,1 Constantine S Mitsiades,1 Teru Hideshima,1 Jacob Laubach,1 Inger S Nijhof,2 Reinier A Raymakers,2 Henk M Lokhorst,2 Paul G Richardson,1 Kenneth C Anderson11Department o...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: van de Donk NW, Görgün G, Groen RW, Jakubikova J, Mitsiades CS, Hideshima T, Laubach J, Nijhof IS, Raymakers RA, Lokhorst HM, Richardson PG, Anderson KC
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Dove Medical Press 2012-08-01
Sarja:Cancer Management and Research
Linkit:http://www.dovepress.com/lenalidomide-for-the-treatment-of-relapsed-and-refractory-multiple-mye-a10695

Internet

http://www.dovepress.com/lenalidomide-for-the-treatment-of-relapsed-and-refractory-multiple-mye-a10695

Samankaltaisia teoksia